.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer last year for an imme...
.On the heels of a phase 3 gain that fell short to make an impression on financiers, Ironwood Pharma...
.Don't quit Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a m...
.Invite to recently's Chutes & Ladders, our roundup of considerable leadership hirings, shootings...
.Celebrating his company's upsized initial public offering (IPO), Septerna chief executive officer J...
.AbbVie has actually come back to the source of its own antipsychotic giant Vraylar looking for an a...
.GenSight Biologics is weeks off of lacking cash. Once more. The biotech simply possesses sufficient...
.Monopar Rehabs is actually recuperating a medicine coming from the dump of AstraZeneca's rare ailme...
.With brand-new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of pr...
.After creating a genetics treatment relationship with Dyno Therapies in 2020, Roche is back for eve...